Li-Fraumeni Syndrome: Why Prevention is Cheaper Than Treatment
Screening patients for Li-Fraumeni syndrome (LFS) costs approximately nine times less than treating the cancer-related complications of the condition, according to new research presented at the European Society of Human Genetics conference. The study, conducted by the EU PREVENTABLE project, found that preventive surveillance costs an average of €6,046 per patient, compared to €53,906 for … Read more